Dow Up0.11% Nasdaq Up0.50%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
71.22 Up 1.60(2.30%) Aug 29, 4:00PM EDT
|After Hours : 71.23 Up 0.01 (0.01%) Aug 29, 4:44PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 191,787   151,552   146,873   136,874  
Cost of Revenue31,210  22,816  24,621  28,054  
Gross Profit 160,577   128,736   122,252   108,820  
Operating Expenses
Research Development107,702  86,166  97,312  88,064  
Selling General and Administrative68,089  60,069  71,809  61,841  
Non Recurring -   -   -   -  
Others3,668  8,957  5,441  9,639  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (18,882) (26,456) (52,310) (50,724)
Income from Continuing Operations
Total Other Income/Expenses Net914  1,276  966  (919)
Earnings Before Interest And Taxes(18,507)(25,518)(51,782)(51,790)
Interest Expense9,221  9,106  7,593  526  
Income Before Tax(27,728)(34,624)(59,375)(52,316)
Income Tax Expense5,774  3,491  2,615  704  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(34,041)(38,453)(62,428)(53,167)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (33,502) (38,115) (61,990) (53,020)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (33,502) (38,115) (61,990) (53,020)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.